Who owns ACHILLES THERAPEUTICS PLC?
- Ticker: ACHL
- CUSIP Number: 00449l102
Tip: Access positions for across all investors
Analyze quarterly positions in Achilles Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Achilles Therapeutics stock
Who bought or sold ACHILLES THERAPEUTICS PLC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Syncona Portfolio | 11M | $9.9M | 0% | Dec 2023 |
|
Fcpm Iii Services B.v. | 2.4M | $2.1M | 100% | Dec 2023 |
|
Artal Group | 2.3M | $2.0M | 0% | Dec 2023 |
|
Baker Bros. Advisors | 2.1M | $1.9M | -18% | Dec 2023 |
|
Redmile Group | 1.6M | $1.4M | 0% | Dec 2023 |
|
Point72 Asset Management | 1.4M | $1.3M | 0% | Dec 2023 |
|
Citadel Advisors | 109k | $96k | 88% | Dec 2023 |
|
Virtu Financial | 40k | $35k | 100% | Dec 2023 |
|
Millennium Management | 31k | $28k | 90% | Dec 2023 |
|
Bank of America Corporation | 23k | $20k | -69% | Dec 2023 |
|
Two Sigma Securities | 15k | $13k | 100% | Dec 2023 |
|
Global Retirement Partners | 3.0k | $2.6k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 989.00 | $879.023200 | 0% | Dec 2023 |
|
Royal Bank of Canada | 35.00 | $0 | 0% | Dec 2023 |
|
Who sold out of Achilles Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Raymond James & Associates | Sep 2023 | 13k | $12k |
Coppell Advisory Solutions | Sep 2023 | 1.0k | $5.6k |